Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.

Kabra Drugs Ltd

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524322

Shareholding pattern / Ownership

Shareholding summary

Sep 2019
  • Promoter23.88%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 23.88% in Sep 2019 qtr

All shareholding details →

Shareholding Trend (Promoter/FII/DII %, real filed periods only)

HolderSep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Latest change
Promoter 23.88%23.88%23.88%23.88%23.88%23.88%23.88%23.88% 0.00 pp
FII ———————— —
DII ———————— —
Mutual funds (within DII) ———————— —
Public (non-institutional) ———————— —

Public (non-institutional) = SEBI's Public total minus FII minus DII, shown only where all three were filed. A dash means that holder category filed nothing for that quarter. Holder counts are as filed (entities, not schemes).

Shareholding Pattern (latest quarter)

Category% holdingShareholders
Grand Total 100.0000 9680
(B) Public 100.0000 9680
(A) Promoter & Promoter Group 0.0000 0
(C1) Shares underlying DRs 0.0000 0
(C) Non Promoter-Non Public 0.0000 0
(C2) Shares held by Employee Trust 0.0000 0

Named Shareholders

Data unavailable.

Related